Origin and funding of the most frequently cited papers in medicine: database analysis

被引:115
作者
Patsopoulos, NA
Analatos, AA
Ioannidis, JPA [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
[2] Univ Thessaly, Sch Med, Larisa, Greece
来源
BMJ-BRITISH MEDICAL JOURNAL | 2006年 / 332卷 / 7549期
关键词
D O I
10.1136/bmj.38768.420139.80
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate changes in the role of academics and the sources of funding for the medical research cited most frequently over the past decade. Design Database analysis. Data sources Web of Knowledge database. Methods For each year from 1994 to 2003, articles in the domain of clinical medicine that had been cited most often by the end of 2004 were identified. Changes in author's affiliations and funding sources were evaluated. Results Of the 289 frequently cited articles, most had at least one author with a university (76%) or hospital (57%) affiliation, and the proportion of articles with each type of affiliation was constant over time. Government or public funding was most common (60% of articles), followed by industry (36%). The proportion of most frequently cited articles funded by industry increased over time (odds ratio 1.17 per year, P = 0.001) and was equal to the proportion funded by government or public sources by 2001. 65 of the 77 most cited randomised controlled trials received funding from industry, and the proportion increased significantly over time (odds ratio 1.59 per year, P = 0.003). 18 of the 32 most cited trials published after 1999 were funded by industry alone. Conclusion Academic affiliations remain prominent among the authors of the most frequently cited medical research. Such research is increasingly funded by industry, often exclusively so. Academics may be losing control of the clinical research agenda.
引用
收藏
页码:1061 / 1063
页数:9
相关论文
共 23 条
[1]  
[Anonymous], 2004, J TRANSL MED, DOI DOI 10.1186/1479-5876-2-5
[2]   Five futures for academic medicine [J].
Awasthi, S ;
Beardmore, J ;
Clark, J ;
Hadridge, P ;
Madani, H ;
Marusic, A ;
Purcell, G ;
Rhoads, M ;
Sliwa-Hähnle, K ;
Smith, R ;
Edejer, TTT ;
Tugwell, P ;
Underwood, T ;
Ward, R .
PLOS MEDICINE, 2005, 2 (07) :606-613
[3]   Scope and impact of financial conflicts of interest in biomedical research - A systematic review [J].
Bekelman, JE ;
Li, Y ;
Gross, CP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (04) :454-465
[4]   Assessing faculty financial relationships with industry - A case study [J].
Boyd, EA ;
Bero, LA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (17) :2209-2214
[5]   Who cares about academic medicine? [J].
Clark, J ;
Tugwell, P .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7469) :751-752
[6]   Clinical research in the United States at a crossroads - Proposal for a novel public-private partnership to establish a National Clinical Research Enterprise [J].
Crowley, WF ;
Sherwood, L ;
Salber, P ;
Scheinberg, D ;
Slavkin, H ;
Tilson, H ;
Reece, EA ;
Catanese, V ;
Johnson, SB ;
Dobs, A ;
Genel, M ;
Korn, A ;
Reame, N ;
Bonow, R ;
Grebb, J ;
Rimoin, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1120-1126
[7]  
Danforth W, 2003, ACAD MED, V78, P237
[8]   Problems with indexing and citation of articles with group authorship [J].
Dickersin, K ;
Scherer, R ;
Suci, EST ;
Gil-Montero, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (21) :2772-2774
[9]  
DICKERSIN K, 2002, JAMA-J AM MED ASSOC, V287, P272
[10]   Are randomised controlled trials in the BMJ different? [J].
Egger, M ;
Bartlett, C ;
Jüni, P .
BRITISH MEDICAL JOURNAL, 2001, 323 (7323) :1253-1254